Clinical Trial Update: Effect of Xalacom® (Latanoprost/Timolol) and Combigan® (Brimonidine/Timolol) Fixed Combination on Intraocular Pressure and Ocular Blood Flow in Patients With Primary Open Angle Glaucoma or Ocular Hypertension [NA]

View source ↗

Summary

A completed clinical trial update evaluating the effects of fixed-combination glaucoma therapies Xalacom (latanoprost/timolol) and Combigan (brimonidine/timolol…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ocular Hypertension
• Open-angle Glaucoma

Drugs mentioned

• Combigan (brimonidine tartrate and timolol maleate)
• Xalacom (latanoprost/timolol)

Snippet

Sponsor: Medical University of Vienna | Conditions: Retina, Ocular Physiology | NA | Status: COMPLETED